Table 2 Cox regression analysis of SDOH and long-term mortality in MetS participants

All-cause mortality

HR (95%CI)

P

HR (95%CI)

P

HR (95%CI)

P

Q1

ref

ref

ref

Q2

1.77(1.46,2.16)

< 0.0001

1.51(1.27,1.80)

< 0.0001

1.55(1.30,1.84)

< 0.0001

Q3

1.74(1.36,2.22)

< 0.0001

2.08(1.67,2.58)

< 0.0001

1.98(1.59,2.46)

< 0.0001

Q4

1.56(1.22,1.99)

< 0.001

2.51(1.96,3.23)

< 0.0001

2.41(1.87,3.12)

< 0.0001

P for trend

< 0.0001

< 0.0001

< 0.0001

Cancer mortality

Q1

ref

ref

ref

Q2

1.43(1.02,2.00)

0.04

1.35(0.97,1.88)

0.08

1.45(1.05,1.99)

0.02

Q3

1.82(1.14,2.89)

0.01

2.38(1.49,3.82)

< 0.001

2.51(1.57,4.02)

< 0.001

Q4

1.17(0.76,1.81)

0.47

2.18(1.38,3.45)

< 0.001

2.45(1.54,3.89)

< 0.001

P for trend

0.11

< 0.0001

< 0.0001

Cardio − cerebrovascular disease mortality

Q1

ref

ref

ref

Q2

2.25(1.67,3.03)

< 0.0001

1.97(1.46,2.64)

< 0.0001

1.98(1.47,2.66)

< 0.0001

Q3

1.52(1.02,2.27)

0.04

2.05(1.41,2.98)

< 0.001

1.78(1.22,2.61)

0.003

Q4

1.54(1.04,2.27)

0.03

2.89(1.96,4.25)

< 0.0001

2.62(1.79,3.84)

< 0.0001

P for trend

0.01

< 0.0001

< 0.0001